Compass Therapeutics (CMPX) Free Cash Flow

Price: $1.46
Market Cap: $201.89M
Avg Volume: 2.03M
Country: US
Industry: Biotechnology
Sector: Healthcare
Beta: 1.187
52W Range: $0.765-4.08
Website: Compass Therapeutics

What is Compass Therapeutics's Free Cash Flow?

  • Compass Therapeutics's annual free cash flow as of FY 2023 is $-40.65M.
  • Compass Therapeutics's quarterly free cash flow as of QQ3 2024 is $-11.10M.

What is Free Cash Flow?

Free cash flow (FCF) is a measure of financial performance calculated as operating cash flow minus capital expenditures. It represents the cash that a company generates after accounting for cash outflows to support operations and maintain its capital assets. FCF is important because it allows a company to pursue opportunities that enhance shareholder value.

How is Free Cash Flow calculated?

The formula for free cash flow is:

Free Cash Flow = Operating Cash Flow - Capital Expenditures

This metric helps investors understand the company's ability to generate cash and its potential to pay dividends or expand.

Related Metrics

Other important metrics to assess Compass Therapeutics's free cash flow financial health include:

  • Free Cash Flow Growth - the rate at which a company's free cash flow is growing:
    • Annual Growth: -18.38%
  • Free Cash Flow Per Share - free cash flow divided by the number of shares outstanding:
    • Annual: $-0.32
  • Free Cash Flow Yield - free cash flow divided by the market capitalization:
    • Annual: -20.51%

These metrics provide insights into Compass Therapeutics's financial health and its ability to generate cash. Comparing these ratios with industry benchmarks can offer a deeper understanding of the company's performance.

Annual Free Cash Flow

$-40.65M

Quarterly Free Cash Flow

$-11.10M

Historical Annual Free Cash Flow
$0.00$0.00-$10.00M-$10.00M-$20.00M-$20.00M-$30.00M-$30.00M-$40.00M-$40.00M-$50.00M-$50.00MFree Cash Flow (Annual)Jul '19Jul '1920202020Jul '20Jul '2020212021Jul '21Jul '2120222022Jul '22Jul '2220232023Jul '23Jul '2320242024
Historical Quarterly Free Cash Flow
$0.00$0.00-$3.00M-$3.00M-$6.00M-$6.00M-$9.00M-$9.00M-$12.00M-$12.00M-$15.00M-$15.00MFree Cash Flow (Quarterly)201920192020202020212021202220222023202320242024
Annual Free Cash Flow Growth
21.09%21.09%4.53%4.53%-12.03%-12.03%-28.59%-28.59%-45.15%-45.15%-61.71%-61.71%Free Cash Flow Growth (%)Jul '19Jul '1920202020Jul '20Jul '2020212021Jul '21Jul '2120222022Jul '22Jul '2220232023Jul '23Jul '2320242024
Annual Free Cash Flow Per Share
$0.17$0.17$-0.00$-0.00$-0.17$-0.17$-0.35$-0.35$-0.52$-0.52$-0.70$-0.70$-0.87$-0.87Free Cash Flow Per ShareJul '19Jul '1920202020Jul '20Jul '2020212021Jul '21Jul '2120222022Jul '22Jul '2220232023Jul '23Jul '2320242024

Compass Therapeutics Historical Financial Metrics

The table below shows various financial metrics for each year, with the latest data available for the last fiscal year 2023.

Year Free Cash Flow Free Cash Flow Growth Free Cash Flow Per Share Free Cash Flow Yield
2023 $-40.65M -18.38% $-0.32 -20.51%
2022 $-34.34M -61.71% $-0.33 -6.49%
2021 $-21.23M 21.09% $-0.34 -10.65%
2020 $-26.91M 16.45% $-0.87 -10.29%
2020 $-32.21M 9.78% $-0.62 -7.27%
2019 $-35.70M 0.00% $-0.69 -8.06%

Related Metrics

Explore detailed financial metrics and analysis for CMPX.

Financial Analysis
Financial Statements Stock Forecast Price Target Technical Analysis Stock Splits Employee Count
Company Intelligence
Ownership Insider Trading SEC Filings Congress Trading News Earnings Call Transcripts
Income & Revenue
Earnings Revenue Revenue Growth Profit Net Income Profit Margin EBITDA Free Cash Flow Revenue Segments
Valuation
Valuation Market Cap Enterprise Value P/E Ratio PEG Ratio P/S Ratio P/B Ratio Book Value
Returns & Ratios
ROIC ROE ROA Current Ratio Quick Ratio Debt/Equity Ratio Earnings Per Share
Balance Sheet
Assets Debt Cash On Hand Shares Outstanding
Dividends
Dividends Dividend Yield Payout Ratio